All issues
09.2009 - Preparing for the time after the crisis by David Große Kathöfer
- A capital market's view on Industrial Biotechnology – proper valuation is the key for picking the right investment opportunities in stormy times by Bernd W. Schneider
- Assessment of thermal-stable polymer nanocomposite techniques by patent citation network analysis by Hsin-Ning Su and Pei-Chun Lee
- Feasibility of Active Ingredient (AI) development for new biocides in the EU by Kaisa Soirinsuo, Elina Kähkönen, Jouko Karjalainen and Katrina Nordström
- How to implement ‘access to medicine’ AND enhance economic performance: business model options for global access by Jürgen Peukert and Thomas Fuggenthaler
05.2009 - Thunderstorms strike the economy by David Große Kathöfer
- The place of chemistry in business by Arthur D. Little
- Chemists of the future by Klaus Müllen
- REACH and the role of stakeholders in its socio-economic analysis by Jan Boris Ingerowski, Daniela Kölsch and Heinrich Tschochohei
- Patent license negotiation: Best practices by Jennifer Giordano-Coltart and Charles W. Calkins
- M&A since Y2K - An overview of chemicals deals involving BRIC countries in the new millennium by Bernd W. Schneider, Stanislav Plakun and Tim-Frederic Slooth
01.2009 - Discussing challenges in the chemical industry for five years by Stefan Picker and David Große Kathöfer
- The effects of the financial crisis on the future of the Chemical Industry by Rudolf Jerrentrup
- Mergers & Acquisitions (M&A) in the Pharmaceutical and Chemical Industries: A lighthouse in choppy waters by Matthias R. Hornke
- Open Source biopharmaceutical innovation- A mode of entry for firms in emerging markets by Minna Allarakhia
- Biotechnology research in South Africa: A benchmarking exercise by Anthipi Pouris and Anastassios Pouris
- REACH effects - Opportunities and risks for transfer pricing by Andreas Boller and Markus Keerl
